Zambon
Pharmaceutical ManufacturingLombardy, Italy1001-5000 Employees
Zambon is a chemical-pharmaceutical company rooted in an Italian family tradition, focused on developing therapies that aim to improve patients' lives. It is headquartered in Milan, Lombardy, and operates manufacturing facilities in Italy, Switzerland, France, China and Brazil, with a global footprint across Europe, the Americas and Asia. Its pharma subsidiary, Zambon SpA, markets products in many countries and concentrates on conditions including pain, respiratory diseases and urological disorders. The group is building a broader pipeline to address serious illnesses such as Parkinson’s disease, Cystic Fibrosis, BOS and NCFB. To support scientific progress and portfolio development, Zambon has created ZBiotech and Zcube to scout, acquire and develop innovative therapies, while Zach-Zambon Chemicals oversees the production chain for APIs and custom synthesis. A recent development includes the 2025 launch of Emylif, a buccal dispersible film formulation of Riluzole for treatment of ALS in adults.